Navigation Links
Study examines liver transplantation after drug induced acute liver failure
Date:7/1/2009

percent) and antibiotics (6 percent). For the entire cohort of transplant recipients, median survival time was 14.4 years. One year estimated survival probabilities were 76 percent, 82 percent, 52 percent, 82 percent, and 79 percent for acetaminophen, antituberculosis, antiepileptics, antibiotics and others, respectively.

"Among the patients who had acute liver failure due to antiepileptics, one-year survival was only 27 percent in patients less than 18 years old compared to 75 percent in patients 18 years old or older," the authors report. Interestingly, these patients were least likely to be listed as status 1 and spent the most time waiting for an organ. Also, the warm and cold ischemia times were longest for this group of patients. "The relatively low survival probability persisted after controlling for these variables in multivariate analysis," the authors report. The reasons for the decreased survival in this group could not be elucidated based on the available data.

Examining the different demographic and clinical factors for each patient and donor, the researchers noted that, "elevated serum creatinine, being on life support, and drug-induced acute liver failure due to antiepileptics (at age less than 18) were found to be independent pretransplant predictors of poor survival."

Using the entire study population, the researchers developed a prognostic model which showed strong predictive ability.

An accompanying editorial by Paul B. Watkins of the Institute for Drug Safety at the Hamner Institutes of Health Sciences, Research Triangle, NC and Paul H. Hayashi of the University of North Carolina , commends the authors for adding valuable information about acute liver failure caused by drugs. In particular, "the identification of poorer outcome for children with anti-epileptic drug induced acute liver failure is intriguing and points out the need for more focused research on drug induced liver injury in pediatric populations
'/>"/>

Contact: Sean Wagner
medicalnews@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Study Supports Wider Use of Statins
2. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
3. The European Association for the Study of the Liver renews publishing partnership with Elsevier
4. Study to see if video games can boost thinking skills in elderly
5. GIE: Gastrointestinal Endoscopy June issue study highlights
6. Study shows 1 in 25 deaths worldwide attributable to alcohol
7. Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation
8. U-M study finds voice box can be preserved, even with the largest cancers
9. Clinical Study Data Indicates that Celliant Reduces Pain
10. Girls Overall Self-Worth Improves With Contact Lens Wear, Study Shows
11. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... China,s leading high-tech,healthcare group, Golden Meditech Company Limited ... pleased to announce today that the Group,s,associate company ... China Holdings Limited, made its debut on the ... secondary offering. The shares of FunTalk started,trading on ... As of today, Golden Meditech ...
(Date:12/17/2009)... Data from a recent Thomson Reuters study show that ... papers in 1998 to nearly 112,000 in 2008. ... 2% of the biomedical literature, has evaluated more than ... While only 27 Chinese-authored papers were selected in 2004, ... set to be even higher in 2009. , Jane ...
(Date:12/17/2009)... hospital clients Rutherford Hospital Inc. (Rutherfordton, N.C.), a management ... management client since 1992, were recently recognized as top-ranked ... ... Brentwood, Tenn. (PRWEB) ... Rutherford Hospital Inc. (Rutherfordton, N.C.), a management client since ...
(Date:12/17/2009)... Discuss Business Strategies, Solutions, and Scientific Studies Important ,for the ... ... MA (PRWEB) December 17, 2009 -- Cambridge Healthtech Institute is ... companies at its 2nd Annual Adopting R&D Informatics Systems conference ... North Convention Center in San Francisco, CA. This meeting has ...
(Date:12/17/2009)... 17 Motionsoft, Inc. announced today that ... Industry (PCI) Data Security Standards (DSS) certification, making ... vendors in the health and wellness space that ... Standard is the result of a collaborative effort ... (Visa International, MasterCard Worldwide, American Express, Discover Financial ...
Breaking Medicine News(10 mins):Health News:Golden Meditech's Associate Company Debuted on NASDAQ 2Health News:China rapidly catching up in research impact 2Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Motionsoft Completes PCI Compliance Certification 2
... that bulimia primarily affects privileged, white teenagers such as ... the show earlier this season. , Rather, girls ... than girls who are white to be bulimic, the ... income bracket studied are 153 percent more likely to ...
... a Long-Term Trend in Infant HealthWHITE PLAINS, N.Y., March 18 ... - a finding that the March of Dimes hopes will ... improved maternal and infant health. The preterm birth rate declined ... among babies born to African American and white women."We,re encouraged ...
... Innovative Electronic Patient Reported Outcomes (ePRO) Solutions and Patient Questionnaires for ... use their state-of-the-art smart phone technology to collect data from patients ... trial. , ... Scottsdale, AZ (PRWEB) March 18, 2009 ...
... (OTC Bulletin Board: NVLX), formerly eFoodSafety.com, Inc. (OTC Bulletin ... permanent tattoo ink designed to be safe and easier to ... shown on February 22, 2009 on PBS member station WSIU. ... ink as well as its use in creating permanent tattoos ...
... Suggests Parents Most Influence Teens, Decisions About SexWASHINGTON, March 18 ... 1% in 2007, according to data released today by the ... second year in a row that the teen birth rate ... decline in the teen birth rate. That is, after ...
... that the PSA test is a far from perfect tool ... offer conflicting views on the value of screening men with ... , But at least one leading oncologist says this much ... family history of prostate cancer should pay attention to a ...
Other Medicine News:Health News:Black girls are 50 percent more likely to be bulimic than white girls 2Health News:Black girls are 50 percent more likely to be bulimic than white girls 3Health News:Preterm Birth Rate Drops 2Health News:Preterm Birth Rate Drops 3Health News:Preterm Birth Rate Drops 4Health News:Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial 2Health News:Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial 3Health News:Nuvilex' Infinitink Tattoo Ink Featured on PBS alt.news 26:46 TV Program 2Health News:Teen Birth Rate Up For Second Year in a Row 2Health News:2 Studies Conflict Over Value of Prostate Cancer Screening 2Health News:2 Studies Conflict Over Value of Prostate Cancer Screening 3
(Date:12/16/2009)... Hospira, Inc. (NYSE: HSP ), ... today announced that it will host a conference call ... projections for 2010 on Thursday, Feb. 4, 2010, at ... its fourth-quarter and full-year 2009 results earlier that morning, ... call. ,, A live webcast of the conference call ...
(Date:12/16/2009)... Dec. 16 AVAX Technologies, Inc. (Pink ... that it recently closed a bridge loan financing ... and Warrant Purchase Agreement (the "Agreement") with Firebird ... Agreement, the Company sold a convertible promissory note, ... amount of US$1,400,000, and issued a warrant to ...
(Date:12/16/2009)... -- International, well-known,scientific experts were surprised ... mg/day),data presented as "extremely promising."[1] More ... clinicians critically reviewed these data.,These experts ... lipid-modifying,treatments, fenofibrate and bezafibrate, in treating ... patients with metabolic syndrome,and type 2 ...
Breaking Medicine Technology:AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3More Preemies Born Among the Poor 62390 1More Preemies Born Among the Poor 62390 2National HIV Non Profit Announces New Name 62386 1National HIV Non Profit Announces New Name 62386 2Mexico City to Build World Class Hub for Medical Research 62382 1Mexico City to Build World Class Hub for Medical Research 62382 2
... prospective, double-blind placebo controlled multi-center studies in patients with ... safety data in patients with focal dystonia and upper ... Academy of Neurology,s (AAN) 61st annual meeting in Seattle. ... plans to file a Biologic License Application (BLA) for ...
... Association Annual Meeting --SEATTLE and CHICAGO, April 28 ... DNDN ) today presented preclinical data demonstrating the ... which targets TRPM8 (a transmembrane cation channel protein), ... demonstrated the ability to reduce BPH alone and ...
Other Medicine Technology:Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 2Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 3Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 4Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 5Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia 4
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Unipolar temporary atrial pacing lead is smaller and thinner than Medtronics standard temporary pacing leads. It is well suited for thin, delicate, atrial tissue....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: